11 – 20 of 98
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women
(
- Contribution to journal › Article
-
Mark
Breast cancer risks associated with missense variants in breast cancer susceptibility genes
(
- Contribution to journal › Article
-
Mark
Polygenic risk modeling for prediction of epithelial ovarian cancer risk
(
- Contribution to journal › Article
-
Mark
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
(
- Contribution to journal › Article
- 2021
-
Mark
“Association of mammographic features with molecular breast tumor profiles”
(
- Contribution to journal › Article
-
Mark
Selenium and Breast Cancer. Is It Protective? Epidemiologic Evidence Regarding Risk and Prognosis
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant
(
- Contribution to journal › Article
- 2020
-
Mark
Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP)
(
- Contribution to journal › Article
- 2019
-
Mark
Hepatic arterial therapy with oxaliplatin and systemic capecitabine for patients with liver metastases from breast cancer
(
- Contribution to journal › Article
-
Mark
Comparison between software volumetric breast density estimates in breast tomosynthesis and digital mammography images in a large public screening cohort
(
- Contribution to journal › Article